Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS
- 8 November 2024
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 39 (1) , 248-256
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Institut National de la Santé et de la Recherche Médicale
This publication has 16 references indexed in Scilit:
- Novel Somatic UBA1 Variant in a Patient With VEXAS SyndromeArthritis & Rheumatology, 2023
- Prediction of Risk for Myeloid Malignancy in Clonal HematopoiesisNEJM Evidence, 2023
- A machine learning approach to predicting risk of myelodysplastic syndromeLeukemia Research, 2021
- Relationship between clone metrics and clinical outcome in clonal cytopeniaBlood, 2021
- Therapeutic options in VEXAS syndrome: insights from a retrospective seriesBlood, 2021
- Myelodysplasia and Bone Marrow Manifestations of Somatic UBA1 Mutated Autoinflammatory DiseaseBlood, 2020
- Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory DiseaseNew England Journal of Medicine, 2020
- Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesNature Medicine, 2020
- The evolutionary dynamics and fitness landscape of clonal hematopoiesisScience, 2020
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015